Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenping Zhu

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
Expert Opinion on Biological Therapy|February 21, 2007
Monoclonal antibody-based therapeutics for leukemiaYiwen Li, Zhenping Zhu
Methods in Molecular Biology (Clifton, N.J.)|September 17, 2013
Construction and production of an IgG-Like tetravalent bispecific antibody, IgG-single-chain Fv fusionDan Lu, Zhenping Zhu
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2009
Construction and production of an IgG-like tetravalent bispecific antibody for enhanced therapeutic efficacyDan Lu, Zhenping Zhu
Current Opinion in Molecular Therapeutics|June 7, 2008
Catumaxomab, a rat/murine hybrid trifunctional bispecific monoclonal antibody for the treatment of cancerJuqun Shen, Zhenping Zhu
Current Medicinal Chemistry|May 25, 2006
Intrabody-based approaches to cancer therapy: status and prospectsBrent R Williams, Zhenping Zhu
Acta Pharmacologica Sinica|May 27, 2005
Recombinant approaches to IgG-like bispecific antibodiesJonathan S Marvin, Zhenping Zhu
Current Opinion in Drug Discovery & Development|March 29, 2006
Bispecific antibodies for dual-modality cancer therapy: killing two signaling cascades with one stoneJonathan S Marvin, Zhenping Zhu
Journal of Molecular Modeling|November 19, 2013
A density functional theory study on oxygen reduction reaction on nitrogen-doped grapheneJing Zhang, Zhijian Wang, Zhenping Zhu
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 26, 2014
Construction of two-dimensional MoS₂/CdS p-n nanohybrids for highly efficient photocatalytic hydrogen evolutionJian Zhang, Zhenping Zhu, Xinliang Feng
Current Cancer Drug Targets|August 22, 2002
Clinical development of angiogenesis inhibitors to vascular endothelial growth factor and its receptors as cancer therapeuticsZhenping Zhu, Peter Bohlen, Larry Witte
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
Expert Opinion on Biological Therapy|February 21, 2007
Monoclonal antibody-based therapeutics for leukemiaYiwen Li, Zhenping Zhu
Methods in Molecular Biology (Clifton, N.J.)|September 17, 2013
Construction and production of an IgG-Like tetravalent bispecific antibody, IgG-single-chain Fv fusionDan Lu, Zhenping Zhu
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2009
Construction and production of an IgG-like tetravalent bispecific antibody for enhanced therapeutic efficacyDan Lu, Zhenping Zhu
Current Opinion in Molecular Therapeutics|June 7, 2008
Catumaxomab, a rat/murine hybrid trifunctional bispecific monoclonal antibody for the treatment of cancerJuqun Shen, Zhenping Zhu
Current Medicinal Chemistry|May 25, 2006
Intrabody-based approaches to cancer therapy: status and prospectsBrent R Williams, Zhenping Zhu
Acta Pharmacologica Sinica|May 27, 2005
Recombinant approaches to IgG-like bispecific antibodiesJonathan S Marvin, Zhenping Zhu
Current Opinion in Drug Discovery & Development|March 29, 2006
Bispecific antibodies for dual-modality cancer therapy: killing two signaling cascades with one stoneJonathan S Marvin, Zhenping Zhu
Journal of Molecular Modeling|November 19, 2013
A density functional theory study on oxygen reduction reaction on nitrogen-doped grapheneJing Zhang, Zhijian Wang, Zhenping Zhu
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 26, 2014
Construction of two-dimensional MoS₂/CdS p-n nanohybrids for highly efficient photocatalytic hydrogen evolutionJian Zhang, Zhenping Zhu, Xinliang Feng
Current Cancer Drug Targets|August 22, 2002
Clinical development of angiogenesis inhibitors to vascular endothelial growth factor and its receptors as cancer therapeuticsZhenping Zhu, Peter Bohlen, Larry Witte
Pageof 13